Announcing IIR’s Oncology Management Summit & Brochure Available for Download

IIR is introducing the all-new Collaborative Summit for Oncology Management during a time when cancer care is undergoing a period of rapid transformation. As you strive to meet the emerging value mandate, this summit delivers multi-stakeholder perspectives on innovative managed care strategies to effectively manage costs while improving quality and effectiveness of cancer care.

Influence the future of oncology management with these key event take-aways:

● Multi-stakeholder view of the oncology management marketplace

● Lessons learned from payment and healthcare delivery reform pilot programs

● Meet and collaborate with oncology leaders spearheading industry change

Who Should Attend? 

This summit is specially designed for managed care health plan executives working in oncology in:

● Medical management
● Pharmacy
● Operations
● Quality management
● Disease management

The summit is also of interest to Pharmaceutical and Medical Device executives as well as PBMs, specialty pharmacies, hospitals and health systems, and provider groups.

To learn more, download our brochure.

As a reader of the Oncology Care Professionals blog, you can use priority code XP1814BLOG to receive 15% off of the standard rate to register. If you have any questions or need any further information, feel free to email kdevery@iirusa.com or visit the webpage.

We look forward to seeing you in June!

Best,
Oncology Management Team

Visit the Oncology Management Webpage
Follow us on Twitter

Case Studies for Success in Companion Diagnostic Commercialization

Nowhere else will you hear directly from the payers on reimbursement criteria. It's only here where you will have exclusive access to reimbursement and payer-led case studies that provide you with the keys to market victory.

Following are just a few of the case study highlights:

• > Case Study — Prove Product Utility to Health Plans presented by Susan Durham, Director, Special Investigations, STERLING HEALTHPLANS
• > Anticipate and Streamline the Research Determinations of Major Payers presented by Kim Huddleston, Manager, Benefits Integrity, WINDSOR HEALTH GROUP
• > Case Study — Strategic Decision Points in the Reimbursement of Companion Diagnostics presented by Kathleen Claessens, Director, Federal Health Policy and Reimbursement, ROCHE
• > Build Your Rx/Dx Strategy within the Current and Projected Market Outlook: Domestically and Internationally presented by Kathryn Becker, Global Marketing Director, ABBOTT MOLECULAR

For more information on The Future of Companion Diagnostics Commercialization Summit, download the brochure to view the full agenda to find out more about these case studies and the rest of the agenda.  As a reader of this blog, when you register to join us and mention code XP1813BLOG, you’ll save 15% off the standard rate. With this discount, you also receive access to the Medical Devices Pricing, Reimbursement and Market Access Forum!

This will also be located with the Medical Devices Pricing, Reimbursement and Market Access Forum! They will take place in Boston this May 22-23, 2013. Feel free to email me with any questions you have about these events.

Medical Device Forum Spotlight: Strategically Price Your Medical Technologies for the New Era in Healthcare

Establishing the right price point for a new medical device is essential, but is also extremely complex. If you aim too high, your product might only become available to a niche market. If you aim too low, you might undervalue your device and not earn as much as you have the potential for. This determination is one that must be made sooner rather than later, as it directs the rest of the commercial strategy for the product. In this session, get a holistic framework and other tools to adapt your pricing in the face of the “New Healthcare Buyer” and rapidly changing healthcare marketplace.  This May at the Medical Device Pricing, Reimbursement and Market Access Forum, we'll address this during the  session Strategically Price Your Medical Technologies for the New Era in Healthcare.

Medical Device Pricing, Reimbursement and Market Access Forum will take place May 22-23, 2013 in Boston, Massachussets. If you'd like to know more about this program, download the agenda. If you'd like to join us, as a reader of this blog when you register to join us and mention code XP1813BLOG, you'll save 10% off the standard rate.

Featured session: Strategically Price Your Medical Technologies for the New Era in Healthcare

Featured speaker: Christopher Provines, Founder, VALUE VANTAGE PARTNERS

About the session: Chris provides a dynamic and holistic framework for medical technology companies to think through the strategic issues and critical inputs for defining a winning pricing strategy. He discusses how to use the framework and other tools to adapt
your pricing in the face of “New Healthcare Buyer” and rapidly changing healthcare marketplace. Select case studies are used to provide key insights to inform your pricing strategies.

Current State of Government Reporting: Will We all Follow Texas?

Our guest post today was provided by Alliance Life Sciences

As medical costs increase and states decide how they will handle Obama’s Affordable Care Act, they will look to the manufacturer to offset these increased costs. Expect more states to follow Texas in enacting new regulations, and revising and expanding reporting obligations. This will mean that reporting and calculation requirements will vary for many of the states, in addition to the new Federal Government mandates.

The new Texas regulation includes:

• That the manufacturers submit pricing data for eligible pharmacies located in Texas, if readily available, as opposed to those located in the entire US. In the event a manufacturer does not have a single price point for a product they must report the range of prices (high and low) and then calculate the weighted average for each product each period.

Texas is expanding price reporting to include:

- Direct Price to Chain Pharmacy
- Direct Price to Long Term Care Pharmacy 
- Direct Price to Pharmacy 
- Direct Price to Wholesaler/Distributer

 • Manufacturers should not include prices excluded from Medicaid Best Price including prices to 340b covered entities when determining price points.

Monthly Reporting:

• The manufacturer is responsible for the correctness of the AWP, even though they do not play a role in the third-party price reporting compendia’s decision regarding their publication of the AWPs.

• All price updates must be provided, except, Average Manufacturer Price (AMP) updates, to the Commission by the 10th day of each month.

• Forecasted price concessions must be included in calculations for a product launch if the manufacturer has this information in its internal business records.

• Manufacturers must update the Commission with change to formulation, product status, or availability.


Want to learn more? Alliance Life Sciences will be attending the 5th annual Government Programs Summit in just two weeks in Baltimore, MD. It's not too late to register! As a reader of this blog, you get a 15% discount off the standard rate when using code XP1851BLOG to join. To learn more, download our brochure.

Look Who’s Attending the Government Programs Summit

In just three weeks the 5th annual Government Programs Summit will bring together the most drug pricing, contracting and compliance executives on the east coast. These executives come to Baltimore each year to get the most comprehensive, up to date information on the reimbursement programs affecting your business, including MDRP, 340B, Medicare Part D, Part B, TRICARE, VA, and OIG. Branded and generic manufacturers, large and small pharma all come together for this exciting event.

340B Prime Vendor Program/Apexus * Acorda Therapeutics * Afaxys * Akrimax Pharmaceuticals * Alliance Life Science Consulting Group * AmerisourceBergen Drug Company * APP Pharmaceuticals * Argus Health Systems * Banner Pharmacaps * Baxter International * Blue Fin Group * Capital Wholesale Drug * Cardinal Health * Celgene * Children's Hospital * CHKD * CIS * Daiichi Sankyo * Dendreon Corporation * Department of Veteran Affairs * Eli Lilly * Epstein Becker & Green PC * Forest Laboratories * Fresenius Kabi * Genzyme * GlaxoSmithKline * Gold Standard * Hersa ORO * HighPoint Solutions * Horizon Pharma * Hospira * Janssen * JHP Pharmaceuticals * John Hopkins * Johnson & Johnson * Keenan* LEO Pharma * McKesson * MedImmune * Merck * Merck Sharp & Dohme* Mercy St. Vincent Medical Center * MLEE Consulting * Morgan Lewis & Bockius * Myers & Stauffer * Mylan Pharmaceuticals * New Hanover Regional Medical Center * New York Downtown Hospital * North Carolina Medicaid * Novartis * Office of Pharmacy Affairs HRSA * Outlaw Group * Paragon Solutions * Pfizer * Prince George's County Health Department * Procter & Gamble * Reckitt Benckiser Pharmaceuticals * Revitas * Roper St. Francis * Sandoz * Sanofi * Script Care * Shire Regenerative Medicine * Smith Drug Company * Sunovion * Teva Health Systems * UCB Pharma * University of Virginia * Upsher Smith Laboratories * UVA Health System * Vertex Pharmaceuticals * Walgreens * West -Ward Pharms * Wockhardt * Xerox State Healthcare *

The event is just weeks away, don’t forget to register AND remember to book your hotel room, as we are close to selling out! To learn more, download our full agenda.

Government Programs Summit will take place March 11-13, 2013 in Baltimore, MD. As a reader of this blog, you get a 15% discount off the standard rate when using code XP1851BLOG to join. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

Cheers,
The Government Programs Summit Team

GP Summit Homepage
GP Summit Twitter

Obama Administration Sets Final Rules Regarding Essential Health Benefits

This week the Obama Administration announced the final rules and guidelines insures must follow regarding Essential Health Benefits. The wait is over, and insures and states are one step closer to implementing a concrete plan for their federal and state health exchanges. The Affordable Health Care Act was created to help individuals choose a program that best suits their needs, however there have been questions on what types of coverage will be provided for both mental health and substance abuse.

The essential health benefits include ambulatory patient services; emergency care; hospitalization; maternity and newborn care; mental health and substance use disorder services, including behavioral health treatment; prescription drugs; rehabilitative and rehabilitative services and devices; laboratory services; preventive and wellness services, and chronic disease management; and pediatric services, including dental and vision care. 


Want to learn more about the Healthcare Reform and How the Delivery of Healthcare Will Change? Government Programs Summit will take place in just a few weeks! It's not too late to register. To view our program, download our brochure.

As a reader of this blog, you get a 15% discount off the standard rate when using code XP1851BLOG to register here. We hope to see you March 11-13, 2013 in Baltimore, MD.

Innovative Care Models for Dual Eligibles

There are different models of care for managing dual eligibles and it is vital to evaluate strengths and weaknesses when deciding which model to use. At the D.U.A.L.S. forum on April 4 – 5 in Baltimore, you’ll hear about the following speakers present on different care models:

• Austin Ifedirah, Vice President of Medicare at GATEWAY HEALTHPLAN will share his insight into caring for the dual eligible population through Special Needs Plans (SNPs).

• Anthony Evans, Vice President of Integrated Health at CARESOURCE, will discuss the strengths and weaknesses of using a managed care model and share some of the financial considerations you must take into account.

• Rachel Richards, Vice President of Government Relations at SENIORLINK, Katherine Anderson, National Vice President of Strategy and Development for Medicare-Medicaid Enrollees at UNITEDHEALTH COMMUNITY & STATE, and Greg Nersessian, Principal at HEALTH MANAGEMENT ASSOCIATES discuss new managed care models to manage non-medical risk since MCOs serving duals will need new capabilities to meet these members' medical and non-medical needs.

 • Meryl Friedman Price, President at HEALTH POLICY MATTERS will discuss which models of care are best for dual eligibles with serious mental illnesses.

To find out more about the 2013 program, download the agenda.

As a member of the D.U.A.L.S. forum blog, you get a 15% discount off the standard rate when using code XP1804LINK to register. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you in Baltimore this spring!

Best,
The D.U.A.L.S. Forum Team

The D.U.A.L.S. Homepage
The D.U.A.L.S. Twitter

Register Today for the Government Programs Summit – Get Your 340B Updates

The 340B drug discount program is going through dynamic times. The Health Resources and Services Administration began auditing covered entities in 2012 to minimize the risk of diversion and protect manufacturers from duplicate discounts, and manufacturers are preparing to conduct audits of their own this year.

At the 5th annual Government Programs Summit, we know how important the 340B Program is to the industry and how compliance and program integrity are crucial for continued success, so for the first time we are partnering with Apexus on the full day 340B University.

Learn from key players involved in the program, including HRSA officers, health care providers, industry representatives and representatives from the Prime Vendor Program.

Our sessions include:

• Pharmacy Models in the 340B Program

• 340B Policy and Compliance Tools

• 340B Pricing Impact on Manufacturers and Wholesalers

• Clarify the 340B Audits Process

To learn more, download our brochure.

Government Programs Summit will take place March 11-13, 2013 in Baltimore, MD. As a member of this LinkedIn group, you get a 15% discount off the standard rate when using code XP1851LINK to register here. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

 Cheers, The Government Programs Summit Team

Visit our Homepage
Follow us on Twitter: https://twitter.com/healthcarebiz

Last Chance to Register for the Medicare Congress

Online registration closes this Sunday, February 10th. Onsite registration is available all three days of the conference. This is also the last chance to partner with The Medicare Congress. Partnership with the Medicare Congress has become an integral part of their marketing mix, developing a hard-to-achieve blend of branding, positioning, association and face-to-face interaction with industry leaders.

At the Medicare Congress, you will learn how to:

● Increase quality — Increase quality including lowering hospital readmission rates, preemptively reach out to members for engagement and more. Learn how leading retail brands are using mobile to derive loyalty

 ● Increase programming — Examine new program opportunities, as well as best practices to utilize your current networks for expansion

● Increase star ratings — Attend the full-day summit dedicated to tactical ways to increase your star ratings in the most cost-efficient ways

● Increase knowledge sharing — Reconnect with colleagues and make new connections at the must-attend industry event.

Want to learn more? Join us next week, February 11-13 in Phoenix, AZ! Use code XP1807BLOG today and save 15% off of the standard rate when you register. If you have any questions about the agenda or event, feel free to email Kate Devery at kdevery@iirusa.com or visit the homepage.

 Cheers,

The Medicare Congress Team

Visit our homepage
Follow us on Twitter: